Resumen de Atomoxetine as a treatment for attention déficit hiperactivity disorder: a literature review

Stefanny Sanchez Vasquez, Marcelo Adrián Estrin

• Introduction: Attention Deficit Hyperactivity Disorder (ADHD) is an increasingly common neurobiological disorder with some therapeutic variants. Atomoxetine is a non-stimulant, potent and selective inhibitor with a tendency to be used in this condition.Objective: to analyze the results of Atomoxetine in terms of dependence and effectiveness in the symptomatic control of Attention Deficit Hyperactivity Disorder.Method: a search for information was carried out in the PubMed database using inclusion and exclusion criteria where 12 articles were analyzed, including case-control studies, clinical studies and randomized controlled trials. Results: a total of 12 articles were identified, 6 of which provided substantial information on the use of Atomoxetine, effectiveness, and risk/benefit versus placebos and stimulant pharmacotherapy. Conclusion: Atomoxetine is a safe and effective drug for the treatment of ADHD because of the low risk of dependence and side effects compared to other drugs already in use